The study aims to compare the effectiveness of low doses of sugammadex versus neostigmine in reversing moderate neuromuscular blocks induced by rocuronium.
Randomized controlled trial design
Participants received low doses of either sugammadex or neostigmine
Assessment of neuromuscular block reversal effectiveness
Sugammadex showed a faster reversal time compared to neostigmine
Both drugs were effective in reversing the neuromuscular block
No significant side effects were reported for either drug
Abstract
Registered retrospectively at ClinicalTrials.gov with registration number NCT05718934 on 2023-02-08.